USPH Total Current Assets vs Net Receivables Analysis
USPH Stock | USD 101.83 1.30 1.29% |
US Physicalrapy financial indicator trend analysis is much more than just breaking down US Physicalrapy prevalent accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether US Physicalrapy is a good investment. Please check the relationship between US Physicalrapy Total Current Assets and its Net Receivables accounts. Check out World Market Map to better understand how to build diversified portfolios, which includes a position in US Physicalrapy. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in american community survey. For more detail on how to invest in USPH Stock please use our How to Invest in US Physicalrapy guide.
Total Current Assets vs Net Receivables
Total Current Assets vs Net Receivables Correlation Analysis
The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of US Physicalrapy Total Current Assets account and Net Receivables. At this time, the significance of the direction appears to have very strong relationship.
The correlation between US Physicalrapy's Total Current Assets and Net Receivables is 0.84. Overlapping area represents the amount of variation of Total Current Assets that can explain the historical movement of Net Receivables in the same time period over historical financial statements of US Physicalrapy, assuming nothing else is changed. The correlation between historical values of US Physicalrapy's Total Current Assets and Net Receivables is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Total Current Assets of US Physicalrapy are associated (or correlated) with its Net Receivables. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Net Receivables has no effect on the direction of Total Current Assets i.e., US Physicalrapy's Total Current Assets and Net Receivables go up and down completely randomly.
Correlation Coefficient | 0.84 |
Relationship Direction | Positive |
Relationship Strength | Strong |
Total Current Assets
The total value of all assets that are expected to be converted into cash within one year or during the normal operating cycle.Net Receivables
Most indicators from US Physicalrapy's fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into US Physicalrapy current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out World Market Map to better understand how to build diversified portfolios, which includes a position in US Physicalrapy. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in american community survey. For more detail on how to invest in USPH Stock please use our How to Invest in US Physicalrapy guide.As of now, US Physicalrapy's Enterprise Value Over EBITDA is increasing as compared to previous years. The US Physicalrapy's current Enterprise Value Multiple is estimated to increase to 17.58, while Selling General Administrative is projected to decrease to under 26.7 M.
2021 | 2022 | 2023 | 2024 (projected) | Gross Profit | 117.2M | 112.0M | 112.0M | 117.6M | Total Revenue | 495.0M | 553.1M | 604.8M | 635.0M |
US Physicalrapy fundamental ratios Correlations
Click cells to compare fundamentals
US Physicalrapy Account Relationship Matchups
High Positive Relationship
High Negative Relationship
US Physicalrapy fundamental ratios Accounts
2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
Total Assets | 560.8M | 594.4M | 749.4M | 858.2M | 1.0B | 1.1B | |
Other Current Liab | 30.9M | 59.7M | 45.7M | 37.4M | 55.3M | 58.1M | |
Total Current Liabilities | 60.6M | 93.5M | 83.5M | 85.5M | 102.2M | 107.3M | |
Total Stockholder Equity | 240.3M | 276.2M | 295.6M | 315.8M | 476.2M | 500.0M | |
Property Plant And Equipment Net | 103.7M | 103.3M | 119.4M | 127.8M | 129.5M | 136.0M | |
Net Debt | 114.3M | 78.1M | 194.5M | 263.7M | 105.8M | 111.1M | |
Retained Earnings | 184.4M | 212.0M | 223.6M | 232.9M | 223.8M | 235.0M | |
Accounts Payable | 2.5M | 1.3M | 6.5M | 6.5M | 3.9M | 4.1M | |
Cash | 23.5M | 32.9M | 28.6M | 31.6M | 152.8M | 160.5M | |
Non Current Assets Total | 475.5M | 506.7M | 654.3M | 746.9M | 794.7M | 834.4M | |
Cash And Short Term Investments | 23.5M | 32.9M | 28.6M | 31.6M | 152.8M | 160.5M | |
Net Receivables | 56.1M | 50.9M | 62.4M | 68.6M | 71.8M | 75.4M | |
Common Stock Shares Outstanding | 12.8M | 12.8M | 12.9M | 13.0M | 14.2M | 12.9M | |
Liabilities And Stockholders Equity | 560.8M | 594.4M | 749.4M | 858.2M | 1.0B | 1.1B | |
Other Current Assets | 5.8M | 3.8M | 4.2M | 11.1M | 8.7M | 9.2M | |
Other Stockholder Equity | 55.8M | 64.0M | 71.9M | 78.7M | 249.5M | 261.9M | |
Total Liab | 181.4M | 184.4M | 297.0M | 373.6M | 375.8M | 394.6M | |
Property Plant And Equipment Gross | 103.7M | 103.3M | 97.9M | 208.0M | 214.4M | 225.1M | |
Total Current Assets | 85.4M | 87.6M | 95.2M | 111.3M | 233.4M | 245.0M | |
Short Long Term Debt Total | 137.8M | 111.0M | 223.1M | 295.3M | 258.6M | 271.5M | |
Non Currrent Assets Other | 1.5M | 1.5M | (28.7M) | (26.4M) | 158.0K | 165.9K | |
Non Current Liabilities Total | 120.8M | 90.9M | 213.5M | 288.1M | 273.7M | 287.3M | |
Short Term Debt | 27.2M | 32.4M | 31.3M | 41.6M | 42.9M | 45.1M | |
Intangible Assets | 52.6M | 56.3M | 86.4M | 108.8M | 109.7M | 115.2M | |
Good Will | 317.7M | 345.6M | 434.7M | 494.1M | 509.6M | 484.1M | |
Common Stock Total Equity | 148K | 149K | 150K | 151K | 173.7K | 144.3K | |
Common Stock | 149K | 150K | 151K | 152K | 172K | 147.0K | |
Other Assets | 1.5M | 14.1M | 1.6M | 1.6M | 1.9M | 2.1M | |
Long Term Debt | 50.4M | 16.6M | 117.6M | 175.8M | 139.0M | 145.9M | |
Property Plant Equipment | 22.1M | 21.7M | 119.4M | 127.8M | 146.9M | 154.3M | |
Other Liab | 10.2M | 12.3M | 21.7M | 34.3M | 39.5M | 41.5M | |
Net Tangible Assets | 7.7M | 6.6M | (225.5M) | (287.1M) | (258.4M) | (245.4M) | |
Noncontrolling Interest In Consolidated Entity | 930K | 1.4M | 1.5M | 1.6M | 1.4M | 1.3M | |
Retained Earnings Total Equity | 167.4M | 184.4M | 212.0M | 224.4M | 258.1M | 158.3M | |
Long Term Debt Total | 38.4M | 50.4M | 16.6M | 117.6M | 135.2M | 142.0M |
Currently Active Assets on Macroaxis
MSFT | Microsoft | |
GM | General Motors | |
CRM | Salesforce | |
MSFT | Microsoft | |
GOOG | Alphabet Inc Class C |
Check out World Market Map to better understand how to build diversified portfolios, which includes a position in US Physicalrapy. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in american community survey. For more detail on how to invest in USPH Stock please use our How to Invest in US Physicalrapy guide.You can also try the Commodity Directory module to find actively traded commodities issued by global exchanges.
Complementary Tools for USPH Stock analysis
When running US Physicalrapy's price analysis, check to measure US Physicalrapy's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy US Physicalrapy is operating at the current time. Most of US Physicalrapy's value examination focuses on studying past and present price action to predict the probability of US Physicalrapy's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move US Physicalrapy's price. Additionally, you may evaluate how the addition of US Physicalrapy to your portfolios can decrease your overall portfolio volatility.
Money Flow Index Determine momentum by analyzing Money Flow Index and other technical indicators | |
Stock Tickers Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites | |
Risk-Return Analysis View associations between returns expected from investment and the risk you assume | |
Cryptocurrency Center Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency | |
Watchlist Optimization Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm | |
Funds Screener Find actively-traded funds from around the world traded on over 30 global exchanges | |
Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets | |
Sign In To Macroaxis Sign in to explore Macroaxis' wealth optimization platform and fintech modules | |
Portfolio Optimization Compute new portfolio that will generate highest expected return given your specified tolerance for risk | |
Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years | |
Content Syndication Quickly integrate customizable finance content to your own investment portal | |
Bond Analysis Evaluate and analyze corporate bonds as a potential investment for your portfolios. |
Is US Physicalrapy's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of US Physicalrapy. If investors know USPH will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about US Physicalrapy listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth (0.19) | Dividend Share 1.73 | Earnings Share 1.16 | Revenue Per Share 41.242 | Quarterly Revenue Growth 0.048 |
The market value of US Physicalrapy is measured differently than its book value, which is the value of USPH that is recorded on the company's balance sheet. Investors also form their own opinion of US Physicalrapy's value that differs from its market value or its book value, called intrinsic value, which is US Physicalrapy's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because US Physicalrapy's market value can be influenced by many factors that don't directly affect US Physicalrapy's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between US Physicalrapy's value and its price as these two are different measures arrived at by different means. Investors typically determine if US Physicalrapy is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, US Physicalrapy's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.